Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $85.24 million versus the consensus estimate of $62 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.